Clinical Trial Update: The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study [Phase 2]

View source ↗

Summary

A Phase IIa randomized, double-blind, placebo-controlled trial evaluated rosuvastatin in patients with diabetic polyneuropathy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Alejandra Guillermina Miranda Diaz | Conditions: Diabetic Polyneuropathy | Phase 2 | Status: COMPLETED